COPD: Knowing it, Recognizing it and Treating it with Combination Therapies
18,334 views
About :
http://www.medicinaeinformazione.com/ / medicinaeinformazione COPD, chronic obstructive pulmonary disease, is about to become the third leading cause of death worldwide, and in Italy alone it affects 3% of the population, but despite this it is a disease that is little known by the general population and patients themselves are not aware of the importance of consistently following therapies, so much so that therapeutic adherence stops at 62%, despite the fact that today there are drugs available, also used in combination, that can prevent exacerbations and disability resulting from symptoms such as cough, dyspnea, difficulty in performing simple daily tasks such as getting dressed or climbing stairs. It is therefore essential that the population over 40, especially smokers since cigarette smoking is the primary risk factor for developing COPD, know the warning signs that should not be ignored in order to intervene promptly and prevent the progression of the disease. An important role is also played by the general practitioner who follows the patient on a daily basis and can intercept the pathology early, manage any comorbidities especially in old age and explain to the patient that COPD, like all chronic diseases, requires continuous time intake of drugs. Offering each individual patient a personalized therapeutic strategy is the first goal to achieve and research over the years has developed increasingly effective therapeutic combinations, such as triple therapy which in selected patients is able to reduce symptoms, improve lung function and consequently the quality of life. We were saying that COPD, despite its spread, is little known, has a significant diagnostic delay and is often not treated adequately, and to photograph the knowledge and management of COPD, GSK and Doxapharma have carried out two separate studies, both on the general population and on patients from which numerous data emerge that can be used by clinicians to improve the diagnostic therapeutic care pathways of patients with COPD. To present the data emerging from the GSK Doxapharma research, a press conference was organized during which we interviewed: Francesco Blasi - Full Professor of Pneumology - University of Milan Gabriella Levato - General Practitioner, FIMMG Lombardia Gadi Schoenheit - Vice President Doxapharma Andrea Rizzi - Medical Director of the Respiratory Area GSK Italia
1,194,122 views 4 days ago
273,889 views 2 days ago
1,375,967 views 10 days ago
1,194,122 views 4 days ago
500,068 views 5 days ago
133,005 views Streamed 2 days ago
Google AdSense
336 x 280
336 x 280
Up Next
MAX OUT & ABOUT
82,731 views
3 years ago
3 years ago
АвтоСовет Юрича
4,566,125 views
5 years ago
5 years ago
Интересные факты
4,651,310 views
3 years ago
3 years ago
Влад Шериф
36,268 views
1 year ago
1 year ago
АвтоСовет Юрича
1,429,795 views
4 years ago
4 years ago
Товарищ из Завалищ
32,702 views
1 year ago
1 year ago
MAX OUT & ABOUT
50,150 views
3 years ago
3 years ago
Asia Import
694,011 views
5 years ago
5 years ago
Гибрид Авто Сервис HVS OLD
130,446 views
3 years ago
3 years ago
UUBAI
214,356 views
4 years ago
4 years ago
Nejlepší český humor
1,155,493 views
1 year ago
1 year ago
RETRO SHOW OK3
207,598 views
3 years ago
3 years ago
Google AdSense
336 x 280
336 x 280